{Reference Type}: Letter
{Title}: Very high-risk familial hypercholesterolaemia patients in real life: The remaining gap in achieving the current LDL-C targets despite the use of PCSK9 inhibitors.
{Author}: Rallidis LS;Liberopoulos EN;Vlachopoulos C;Skoumas I;Kolovou G;Anastasiou G;Dima I;Tousoulis D;Iliodromitis E;
{Journal}: Atherosclerosis
{Volume}: 309
{Issue}: 0
{Year}: 09 2020
{Factor}: 6.847
{DOI}: 10.1016/j.atherosclerosis.2020.07.018
{Abstract}: